Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 13,199 shares at $30.00 ($396K) on 2023-12-22, disclosed to the SEC on 2023-12-22.
Scheduled sale ($396k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |